LifeOS Genomics

LifeOS Genomics is rated 3 out of 5 in the category biotechnology. Read and write reviews about LifeOS Genomics. LifeOS Genomics was founded in 2015 on the vision of enabling accessible testing for genetic diseases. To realize this vision, we built the QLoci™ system, a fully automated “sample-to-result” molecular screening platform that offers proprietary multiplex digital PCR (mdPCR™) technology. The breakthrough of our mdPCR™ platform is the marriage of up to 100-plex assay capability in a digital PCR-on-chip format and 01% sensitivity, all delivered in a single microfluidic cartridge. This unique ability to provide high multiplicity assays and absolute quantitation with remarkable consistency is a game changer in fulfilling unmet medical needs, particularly in early detection and dynamic therapeutic solutions.